China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Intranasal insulin for prevention of emergence agitation after endoscopic nasal surgery in adults: a randomized, double-blind, placebo-controlled, parallel-group trial'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130646
Registration Time: 2026/08/23
Type: Interventional study
Primary Sponsor: Zigong Fourth People's Hospital(Zigong First-aid Center)
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336973
Published by HT Digital Content Services with permission from Health Daily Digest....